Our results revealed low expression levels of both ALKBH5 and FTO in lung cancer tissues (Figure S3F), with ALKBH5 being the sole enzyme showing negative regulation of HMMR (Figure S3G-H). This evidence concerns the gene ALKBH5 and lung carcinoma.